Contraria Biotech develops vaccines and biopharmaceuticals targeting infectious diseases, with a focus on antimicrobial resistance. The company uses integrated technological platforms for product development.

Contraria Biotech

Padda Health is a venture capital firm that invests in innovative start-ups and SMEs in the healthcare sector, supporting them through a skills network.

Padda Health

EG Stada Italia is involved in the pharmaceutical industry, offering products such as equivalent drugs, consumer healthcare items, and biosimilars, as self-described.

Metric
Company Name	Contraria Biotech	Padda Health	EG Stada Italia
Symbol
MSH ID	COM:CONTRARIABIOTECH	COM:PADDAHEALTH	IT:EGSTADA
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Financial Services & Finance	Healthcare & Health Services
Industry	Biotechnology	Venture Capital	Pharmaceuticals
Country	IT	IT	IT
Stage
Employee Count
Website	contrariabiotech.com	paddahealth.com	egstada.it
LinkedIn		padda-micro-venture-capital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		1.11K
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:CONTRARIABIOTECH

Contraria Biotech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue